Home / Recalls / Pharmedium Services, LLC / D-0079-2017

D-0079-2017 Class II Terminated

Recalled by Pharmedium Services, LLC — Lake Forest, IL

FDA drug recall D-0079-2017 was initiated by Pharmedium Services, LLC on Jul 17, 2015 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes. The recall status is terminated (terminated Jun 23, 2017). Affected quantity: 21506 syringes.

Recall Details

Product Type: Drugs
Report Date: Oct 19, 2016
Initiation Date: Jul 17, 2015
Termination Date: Jun 23, 2017
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 21506 syringes

Product Description

morphine Sulfate, 1 mg per mL (2 mg per 2 mL), in 0.9% Sodium Chloride, Preservative Free (Contains Sulfites), 2 mL Total Volume in a syringe, For IV use, Rx only, PharMEDium, Product code 2R3259.

Reason for Recall

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Distribution Pattern

Nationwide

Code Information

Lot Numbers: 15125021M, 15126043M, 15126064M, 15126065M, 15126066M, 15127091M, 15132014M, 15133011C, 15134006C, 15134007C, 15134062M, 15135063M, 15139087M, 15141002C, 15141040M, 15141041M, 15146081M, 15147036M, 15147037M, 15147122M, 15148003C, 15148012M, 15148119M, 15149003M, 15152004C, 15153006C, 15154002C, 15155007C, 15160009C, 151650003C 151660005C, 151660006C, 151670005C, 151720005C, 151720041C, 151730003M, 151730006C, 151730007C, 151730128M, 151740131M, 151740136M, 151750007C, 151790041C, 151930021M, Exp between 07/15/15-10/12/15

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0079-2017
openFDA file date: Oct 27, 2026
Loaded by RegDataLab: Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Pharmedium Services, LLC

D-1086-2020 Class II — succinylcholine Chloride, 20 mg per 5 mL, 100 mg per 5 mL, 5 mL BD Syringe, For… (Mar 16, 2020)
D-1081-2020 Class II — ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL… (Mar 16, 2020)
D-1092-2020 Class II — fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL 5 mL syringe, For… (Mar 16, 2020)
D-1088-2020 Class II — ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL in 0.9% Sodium Chloride, 5 mL… (Mar 16, 2020)
D-1084-2020 Class II — HYDROmorphone in 0.9% Sodium Chloride HCl, 1 mg per mL, For IV Use, 30 mg per 30… (Mar 16, 2020)
D-1089-2020 Class II — fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500… (Mar 16, 2020)
D-1083-2020 Class II — rocuronium Bromide 10 mg per mL 50 mg per 5 mL, 5 mL BD Syringe, For IV Use… (Mar 16, 2020)
D-1091-2020 Class II — ePHEDrine Sulfate 10 mg per mL 50 mg per 5 mL in 0.9% 5 mL Sodium Chloride 5… (Mar 16, 2020)
D-1087-2020 Class II — rocuronium Bromide, 10 mg per mL, 50 mg per 5 mL, 5 mL BD Syringe, for IV Use… (Mar 16, 2020)
D-1082-2020 Class II — nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP… (Mar 16, 2020)